The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | The standard of care in T-cell lymphoma: challenges and future outlooks
Swaminathan P. Iyer, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into treatment approaches for T-cell lymphoma, highlighting the challenges with treating this disease. Dr Iyer first comments on the heterogeneity of T-cell lymphoma, and the various subsets that exist, and then goes on to explain common treatment approaches and upcoming clinical trials in this space. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
